| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cholesterol O-acyltransferase activity | 8.94e-06 | 3 | 35 | 2 | GO:0034736 | |
| GeneOntologyMolecularFunction | sterol O-acyltransferase activity | 8.94e-06 | 3 | 35 | 2 | GO:0004772 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 1.15e-05 | 171 | 35 | 5 | GO:0015081 | |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 5.44e-05 | 119 | 35 | 4 | GO:0015294 | |
| GeneOntologyMolecularFunction | intracellularly cGMP-activated cation channel activity | 6.23e-05 | 7 | 35 | 2 | GO:0005223 | |
| GeneOntologyMolecularFunction | intracellularly cAMP-activated cation channel activity | 1.33e-04 | 10 | 35 | 2 | GO:0005222 | |
| GeneOntologyMolecularFunction | symporter activity | 1.34e-04 | 150 | 35 | 4 | GO:0015293 | |
| GeneOntologyMolecularFunction | intracellularly cyclic nucleotide-activated monoatomic cation channel activity | 2.30e-04 | 13 | 35 | 2 | GO:0005221 | |
| GeneOntologyMolecularFunction | cyclic nucleotide-activated monoatomic ion channel activity | 2.30e-04 | 13 | 35 | 2 | GO:0043855 | |
| GeneOntologyMolecularFunction | sulfur compound binding | 2.34e-04 | 323 | 35 | 5 | GO:1901681 | |
| GeneOntologyMolecularFunction | cGMP binding | 3.53e-04 | 16 | 35 | 2 | GO:0030553 | |
| GeneOntologyMolecularFunction | solute:sodium symporter activity | 3.83e-04 | 81 | 35 | 3 | GO:0015370 | |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | 4.57e-04 | 207 | 35 | 4 | GO:0046943 | |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | 4.65e-04 | 208 | 35 | 4 | GO:0005342 | |
| GeneOntologyMolecularFunction | fatty-acyl-CoA binding | 6.74e-04 | 22 | 35 | 2 | GO:0000062 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | 6.98e-04 | 627 | 35 | 6 | GO:0022890 | |
| GeneOntologyMolecularFunction | amino acid:sodium symporter activity | 7.38e-04 | 23 | 35 | 2 | GO:0005283 | |
| GeneOntologyMolecularFunction | fatty acid derivative binding | 8.04e-04 | 24 | 35 | 2 | GO:1901567 | |
| GeneOntologyMolecularFunction | amino acid transmembrane transporter activity | 8.18e-04 | 105 | 35 | 3 | GO:0015171 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | 9.42e-04 | 664 | 35 | 6 | GO:0008324 | |
| GeneOntologyMolecularFunction | acyl-CoA binding | 9.45e-04 | 26 | 35 | 2 | GO:0120227 | |
| GeneOntologyMolecularFunction | amino acid:monoatomic cation symporter activity | 1.18e-03 | 29 | 35 | 2 | GO:0005416 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 1.22e-03 | 465 | 35 | 5 | GO:0046873 | |
| GeneOntologyMolecularFunction | modified amino acid transmembrane transporter activity | 1.52e-03 | 33 | 35 | 2 | GO:0072349 | |
| GeneOntologyMolecularFunction | chemokine binding | 1.52e-03 | 33 | 35 | 2 | GO:0019956 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 1.52e-03 | 33 | 35 | 2 | GO:0005217 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | 1.66e-03 | 293 | 35 | 4 | GO:0008514 | |
| GeneOntologyMolecularFunction | organic acid:sodium symporter activity | 1.71e-03 | 35 | 35 | 2 | GO:0005343 | |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | 1.72e-03 | 296 | 35 | 4 | GO:0015291 | |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | 1.83e-03 | 301 | 35 | 4 | GO:0022853 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | 1.86e-03 | 758 | 35 | 6 | GO:0015318 | |
| GeneOntologyMolecularFunction | cyclic nucleotide binding | 2.12e-03 | 39 | 35 | 2 | GO:0030551 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | 2.33e-03 | 793 | 35 | 6 | GO:0015075 | |
| GeneOntologyMolecularFunction | neutral L-amino acid transmembrane transporter activity | 2.34e-03 | 41 | 35 | 2 | GO:0015175 | |
| GeneOntologyMolecularFunction | sodium channel activity | 3.75e-03 | 52 | 35 | 2 | GO:0005272 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | 3.87e-03 | 1180 | 35 | 7 | GO:0022857 | |
| GeneOntologyMolecularFunction | heparin binding | 4.57e-03 | 192 | 35 | 3 | GO:0008201 | |
| GeneOntologyMolecularFunction | cholesterol binding | 4.64e-03 | 58 | 35 | 2 | GO:0015485 | |
| GeneOntologyMolecularFunction | O-acyltransferase activity | 4.80e-03 | 59 | 35 | 2 | GO:0008374 | |
| GeneOntologyMolecularFunction | sulfur compound transmembrane transporter activity | 5.12e-03 | 61 | 35 | 2 | GO:1901682 | |
| GeneOntologyMolecularFunction | serine hydrolase activity | 6.01e-03 | 212 | 35 | 3 | GO:0017171 | |
| GeneOntologyMolecularFunction | transporter activity | 6.26e-03 | 1289 | 35 | 7 | GO:0005215 | |
| GeneOntologyMolecularFunction | sterol binding | 6.88e-03 | 71 | 35 | 2 | GO:0032934 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | 9.37e-03 | 477 | 35 | 4 | GO:0022804 | |
| GeneOntologyMolecularFunction | glycosaminoglycan binding | 1.14e-02 | 268 | 35 | 3 | GO:0005539 | |
| GeneOntologyMolecularFunction | alcohol binding | 1.38e-02 | 102 | 35 | 2 | GO:0043178 | |
| GeneOntologyMolecularFunction | protein tyrosine phosphatase activity | 1.40e-02 | 103 | 35 | 2 | GO:0004725 | |
| GeneOntologyMolecularFunction | amide binding | 1.53e-02 | 299 | 35 | 3 | GO:0033218 | |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | 2.52e-05 | 208 | 35 | 5 | GO:0035725 | |
| GeneOntologyBiologicalProcess | sodium ion transport | 9.51e-05 | 275 | 35 | 5 | GO:0006814 | |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | 1.24e-04 | 922 | 35 | 8 | GO:0098662 | |
| GeneOntologyBiologicalProcess | neutral amino acid transport | 1.43e-04 | 60 | 35 | 3 | GO:0015804 | |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | 1.44e-04 | 942 | 35 | 8 | GO:0098655 | |
| GeneOntologyBiologicalProcess | carboxylic acid transmembrane transport | 1.63e-04 | 163 | 35 | 4 | GO:1905039 | |
| GeneOntologyBiologicalProcess | organic acid transmembrane transport | 1.78e-04 | 167 | 35 | 4 | GO:1903825 | |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | 2.43e-04 | 1017 | 35 | 8 | GO:0098660 | |
| GeneOntologyBiologicalProcess | very-low-density lipoprotein particle assembly | 2.51e-04 | 14 | 35 | 2 | GO:0034379 | |
| GeneOntologyBiologicalProcess | sensory organ morphogenesis | 2.66e-04 | 343 | 35 | 5 | GO:0090596 | |
| GeneOntologyBiologicalProcess | amino acid transport | 3.22e-04 | 195 | 35 | 4 | GO:0006865 | |
| GeneOntologyBiologicalProcess | eye morphogenesis | 3.83e-04 | 204 | 35 | 4 | GO:0048592 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | 4.53e-04 | 1115 | 35 | 8 | GO:0034220 | |
| GeneOntologyBiologicalProcess | monoatomic cation transport | 5.79e-04 | 1157 | 35 | 8 | GO:0006812 | |
| GeneOntologyBiologicalProcess | camera-type eye development | 7.15e-04 | 426 | 35 | 5 | GO:0043010 | |
| GeneOntologyBiologicalProcess | glycerol ether metabolic process | 7.54e-04 | 24 | 35 | 2 | GO:0006662 | |
| GeneOntologyBiologicalProcess | ether lipid metabolic process | 7.54e-04 | 24 | 35 | 2 | GO:0046485 | |
| GeneOntologyBiologicalProcess | cholesterol storage | 8.86e-04 | 26 | 35 | 2 | GO:0010878 | |
| GeneOntologyBiologicalProcess | amino acid transmembrane transport | 1.10e-03 | 120 | 35 | 3 | GO:0003333 | |
| GeneOntologyBiologicalProcess | plasma lipoprotein particle assembly | 1.10e-03 | 29 | 35 | 2 | GO:0034377 | |
| GeneOntologyBiologicalProcess | ether metabolic process | 1.10e-03 | 29 | 35 | 2 | GO:0018904 | |
| GeneOntologyBiologicalProcess | eye development | 1.22e-03 | 480 | 35 | 5 | GO:0001654 | |
| GeneOntologyBiologicalProcess | visual system development | 1.25e-03 | 483 | 35 | 5 | GO:0150063 | |
| GeneOntologyBiologicalProcess | metal ion transport | 1.26e-03 | 1000 | 35 | 7 | GO:0030001 | |
| GeneOntologyBiologicalProcess | sensory organ development | 1.30e-03 | 730 | 35 | 6 | GO:0007423 | |
| GeneOntologyBiologicalProcess | sensory system development | 1.35e-03 | 491 | 35 | 5 | GO:0048880 | |
| GeneOntologyBiologicalProcess | protein-lipid complex assembly | 1.43e-03 | 33 | 35 | 2 | GO:0065005 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | 1.77e-03 | 1374 | 35 | 8 | GO:0006811 | |
| GeneOntologyCellularComponent | cluster of actin-based cell projections | 3.30e-05 | 223 | 35 | 5 | GO:0098862 | |
| GeneOntologyCellularComponent | intracellular cyclic nucleotide activated cation channel complex | 5.69e-05 | 7 | 35 | 2 | GO:0017071 | |
| GeneOntologyCellularComponent | brush border | 1.18e-04 | 152 | 35 | 4 | GO:0005903 | |
| GeneOntologyCellularComponent | brush border membrane | 3.60e-04 | 83 | 35 | 3 | GO:0031526 | |
| GeneOntologyCellularComponent | cell projection membrane | 7.10e-04 | 431 | 35 | 5 | GO:0031253 | |
| Domain | Sterol_acyltranf_meta | 3.22e-06 | 2 | 34 | 2 | IPR030687 | |
| Domain | Oat_ACAT_DAG_ARE | 9.64e-06 | 3 | 34 | 2 | IPR014371 | |
| Domain | CLZ | 1.93e-05 | 4 | 34 | 2 | PF16526 | |
| Domain | CLZ_dom | 1.93e-05 | 4 | 34 | 2 | IPR032406 | |
| Domain | Na/ntran_symport_orphan | 3.21e-05 | 5 | 34 | 2 | IPR002438 | |
| Domain | MBOAT_fam | 1.75e-04 | 11 | 34 | 2 | IPR004299 | |
| Domain | MBOAT | 1.75e-04 | 11 | 34 | 2 | PF03062 | |
| Domain | K_chnl_volt-dep_EAG/ELK/ERG | 2.89e-04 | 14 | 34 | 2 | IPR003938 | |
| Domain | cNMP-bd_CS | 3.80e-04 | 16 | 34 | 2 | IPR018488 | |
| Domain | NA_NEUROTRAN_SYMP_2 | 4.83e-04 | 18 | 34 | 2 | PS00754 | |
| Domain | NA_NEUROTRAN_SYMP_3 | 5.39e-04 | 19 | 34 | 2 | PS50267 | |
| Domain | SNF | 5.39e-04 | 19 | 34 | 2 | PF00209 | |
| Domain | Na/ntran_symport | 5.39e-04 | 19 | 34 | 2 | IPR000175 | |
| Domain | NA_NEUROTRAN_SYMP_1 | 5.39e-04 | 19 | 34 | 2 | PS00610 | |
| Domain | CNMP_BINDING_1 | 1.54e-03 | 32 | 34 | 2 | PS00888 | |
| Domain | CNMP_BINDING_2 | 1.54e-03 | 32 | 34 | 2 | PS00889 | |
| Domain | cNMP | 1.74e-03 | 34 | 34 | 2 | SM00100 | |
| Domain | cNMP_binding | 1.74e-03 | 34 | 34 | 2 | PF00027 | |
| Domain | cNMP-bd_dom | 1.84e-03 | 35 | 34 | 2 | IPR000595 | |
| Domain | CNMP_BINDING_3 | 1.84e-03 | 35 | 34 | 2 | PS50042 | |
| Domain | cNMP-bd-like | 2.17e-03 | 38 | 34 | 2 | IPR018490 | |
| Domain | - | 3.44e-03 | 48 | 34 | 2 | 2.60.120.10 | |
| Domain | RmlC-like_jellyroll | 3.88e-03 | 51 | 34 | 2 | IPR014710 | |
| Domain | MFS | 8.64e-03 | 77 | 34 | 2 | IPR011701 | |
| Domain | MFS_1 | 8.64e-03 | 77 | 34 | 2 | PF07690 | |
| Domain | TRYPSIN_SER | 1.17e-02 | 90 | 34 | 2 | IPR033116 | |
| Domain | TRYPSIN_HIS | 1.51e-02 | 103 | 34 | 2 | IPR018114 | |
| Domain | TRYPSIN_SER | 1.59e-02 | 106 | 34 | 2 | PS00135 | |
| Domain | TRYPSIN_HIS | 1.62e-02 | 107 | 34 | 2 | PS00134 | |
| Domain | MFS | 1.65e-02 | 108 | 34 | 2 | PS50850 | |
| Domain | Peptidase_S1A | 1.79e-02 | 113 | 34 | 2 | IPR001314 | |
| Domain | Ion_trans_dom | 1.82e-02 | 114 | 34 | 2 | IPR005821 | |
| Domain | Ion_trans | 1.82e-02 | 114 | 34 | 2 | PF00520 | |
| Domain | TRYPSIN_DOM | 1.85e-02 | 115 | 34 | 2 | PS50240 | |
| Domain | Tryp_SPc | 1.92e-02 | 117 | 34 | 2 | SM00020 | |
| Pathway | REACTOME_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE | 3.73e-05 | 32 | 29 | 3 | MM14957 | |
| Pathway | REACTOME_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE | 4.10e-05 | 33 | 29 | 3 | M188 | |
| Pathway | REACTOME_SLC_TRANSPORTER_DISORDERS | 4.75e-05 | 99 | 29 | 4 | M27474 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 6.68e-05 | 108 | 29 | 4 | M823 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 6.92e-05 | 109 | 29 | 4 | MM15074 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | 1.12e-04 | 238 | 29 | 5 | MM15076 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | 1.39e-04 | 249 | 29 | 5 | M5988 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | 3.66e-04 | 681 | 29 | 7 | MM14985 | |
| Pathway | REACTOME_DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS | 4.46e-04 | 177 | 29 | 4 | M27476 | |
| Pathway | KEGG_STEROID_BIOSYNTHESIS | 5.45e-04 | 17 | 29 | 2 | M5872 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | 5.84e-04 | 736 | 29 | 7 | M27287 | |
| Pathway | REACTOME_LDL_CLEARANCE | 6.13e-04 | 18 | 29 | 2 | MM15565 | |
| Pathway | REACTOME_LDL_CLEARANCE | 6.84e-04 | 19 | 29 | 2 | M27846 | |
| Pathway | REACTOME_NA_CL_DEPENDENT_NEUROTRANSMITTER_TRANSPORTERS | 6.84e-04 | 19 | 29 | 2 | M27362 | |
| Pathway | REACTOME_NA_CL_DEPENDENT_NEUROTRANSMITTER_TRANSPORTERS | 6.84e-04 | 19 | 29 | 2 | MM15107 | |
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 18269457 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 15992359 | ||
| Pubmed | Twist1 homodimers enhance FGF responsiveness of the cranial sutures and promote suture closure. | 9.84e-07 | 2 | 35 | 2 | 18471809 | |
| Pubmed | Human beta-tryptase is a ring-like tetramer with active sites facing a central pore. | 9.84e-07 | 2 | 35 | 2 | 9521329 | |
| Pubmed | The structure of the human betaII-tryptase tetramer: fo(u)r better or worse. | 9.84e-07 | 2 | 35 | 2 | 10500112 | |
| Pubmed | Ezetimibe blocks the internalization of NPC1L1 and cholesterol in mouse small intestine. | 9.84e-07 | 2 | 35 | 2 | 22811412 | |
| Pubmed | Human mast cell tryptase: multiple cDNAs and genes reveal a multigene serine protease family. | 9.84e-07 | 2 | 35 | 2 | 2187193 | |
| Pubmed | Potentiating the antitumour response of CD8(+) T cells by modulating cholesterol metabolism. | 9.84e-07 | 2 | 35 | 2 | 26982734 | |
| Pubmed | Characterization of a tryptase mRNA expressed in the human basophil cell line KU812. | 9.84e-07 | 2 | 35 | 2 | 8434231 | |
| Pubmed | Quantitative analysis of the expression of ACAT genes in human tissues by real-time PCR. | 9.84e-07 | 2 | 35 | 2 | 14729857 | |
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 16647063 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 15567416 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 10391906 | ||
| Pubmed | The human mast cell tryptase tetramer: a fascinating riddle solved by structure. | 9.84e-07 | 2 | 35 | 2 | 10708850 | |
| Pubmed | Cloning and characterization of a second complementary DNA for human tryptase. | 9.84e-07 | 2 | 35 | 2 | 2203827 | |
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 17449330 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 31337736 | ||
| Pubmed | Organization of human ACAT-2 gene and its cell-type-specific promoter activity. | 9.84e-07 | 2 | 35 | 2 | 11401500 | |
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 10898108 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 18000807 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 15158756 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 16230498 | ||
| Pubmed | Expression of cyclic nucleotide-gated cation channels in non-sensory tissues and cells. | 2.95e-06 | 3 | 35 | 2 | 7532814 | |
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 18303857 | ||
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 9756920 | ||
| Pubmed | Characterization of genes encoding known and novel human mast cell tryptases on chromosome 16p13.3. | 2.95e-06 | 3 | 35 | 2 | 9920877 | |
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 19748655 | ||
| Pubmed | Amino acid transport across mammalian intestinal and renal epithelia. | 4.12e-06 | 31 | 35 | 3 | 18195088 | |
| Pubmed | 5.90e-06 | 4 | 35 | 2 | 33565061 | ||
| Pubmed | 5.90e-06 | 4 | 35 | 2 | 20133765 | ||
| Pubmed | 5.90e-06 | 4 | 35 | 2 | 15634774 | ||
| Pubmed | 5.90e-06 | 4 | 35 | 2 | 15308631 | ||
| Pubmed | 5.90e-06 | 4 | 35 | 2 | 22669916 | ||
| Pubmed | Cellular pregnenolone esterification by acyl-CoA:cholesterol acyltransferase. | 5.90e-06 | 4 | 35 | 2 | 22474282 | |
| Pubmed | The heteromeric cyclic nucleotide-gated channel adopts a 3A:1B stoichiometry. | 9.82e-06 | 5 | 35 | 2 | 12432397 | |
| Pubmed | 9.82e-06 | 5 | 35 | 2 | 15906377 | ||
| Pubmed | 9.82e-06 | 5 | 35 | 2 | 10843716 | ||
| Pubmed | New developments in the genetics and activation of mast cell proteases. | 1.47e-05 | 6 | 35 | 2 | 12217407 | |
| Pubmed | cGMP and cyclic nucleotide-gated channels participate in mouse sperm capacitation. | 1.47e-05 | 6 | 35 | 2 | 22192355 | |
| Pubmed | 2.74e-05 | 8 | 35 | 2 | 25446841 | ||
| Pubmed | 2.74e-05 | 8 | 35 | 2 | 9756919 | ||
| Pubmed | 2.74e-05 | 8 | 35 | 2 | 12737212 | ||
| Pubmed | 3.53e-05 | 9 | 35 | 2 | 20570969 | ||
| Pubmed | Integration of FGF and TWIST in calvarial bone and suture development. | 3.53e-05 | 9 | 35 | 2 | 10751173 | |
| Pubmed | 4.12e-05 | 192 | 35 | 4 | 20602615 | ||
| Pubmed | 4.40e-05 | 10 | 35 | 2 | 16382102 | ||
| Pubmed | 1.17e-04 | 16 | 35 | 2 | 27328943 | ||
| Pubmed | BCL11B regulates sutural patency in the mouse craniofacial skeleton. | 1.17e-04 | 16 | 35 | 2 | 26453795 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | 1.66e-04 | 1201 | 35 | 7 | 35696571 | |
| Pubmed | 2.03e-04 | 113 | 35 | 3 | 30352685 | ||
| Pubmed | The repertoire of solute carriers of family 6: identification of new human and rodent genes. | 2.04e-04 | 21 | 35 | 2 | 16125675 | |
| Pubmed | 5.73e-04 | 35 | 35 | 2 | 18832392 | ||
| Pubmed | 6.41e-04 | 37 | 35 | 2 | 32708917 | ||
| Pubmed | 8.91e-04 | 430 | 35 | 4 | 16303743 | ||
| Cytoband | 7p21.2 | 3.09e-05 | 11 | 35 | 2 | 7p21.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7p21 | 2.12e-03 | 89 | 35 | 2 | chr7p21 | |
| GeneFamily | Cyclic nucleotide gated channels | 7.55e-05 | 10 | 24 | 2 | 250 | |
| GeneFamily | Solute carriers | 1.46e-04 | 395 | 24 | 5 | 752 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-brush_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.77e-06 | 162 | 35 | 4 | 6972d45f4bd4b6522bf93295f7e9dca7c6cba1f3 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Myeloid-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.56e-06 | 166 | 35 | 4 | 0a7992bc673fca546636563ec3fc17a4298ab6b1 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Epcam____brush_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.97e-06 | 168 | 35 | 4 | 35ce3b2b9c9997d4c101da5949c7271d6a6b8f12 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Hematopoietic-Myeloid-CLC+_Mast_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.01e-05 | 173 | 35 | 4 | b9dc42d629d13e63aada5ae49ba0cbb0952c5fe9 | |
| ToppCell | 10x3'2.3-week_14-16-Myeloid_neutrophil-granulo-eo/baso/mast-eosinophil|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.15e-05 | 179 | 35 | 4 | 810972561d1ae5a68389b54ceeac7a49890513a4 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.31e-05 | 185 | 35 | 4 | d602a9b35e86e6f2a14a58e40fc4fb97f5fa3b08 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.58e-05 | 194 | 35 | 4 | 46070fbb0ee0eb9e1801c43b73a15707471056dc | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.58e-05 | 194 | 35 | 4 | abacb6a8d7a9003f2f6c2be0305507f1c1c50347 | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Parm1|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 9.03e-05 | 111 | 35 | 3 | 1847dde68d349114286bc3317be6339666df4aa2 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.4.3|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.61e-04 | 135 | 35 | 3 | 16ae3e31af2430ba5be1523fc18d491974940576 | |
| ToppCell | Severe-Myeloid-Mast-|Severe / Condition, Lineage, Cell class and cell subclass | 1.99e-04 | 145 | 35 | 3 | ce307d45425a5191882078f049f85477eec40b69 | |
| ToppCell | Severe-Myeloid-Mast|Severe / Condition, Lineage, Cell class and cell subclass | 1.99e-04 | 145 | 35 | 3 | e0bfd2ffdbd6c197ef0a04e983396ebd87ef7127 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_atypical|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.11e-04 | 148 | 35 | 3 | b7b5521162effc1024e7c399f690cd86d0b2f750 | |
| ToppCell | facs-Trachea-nan-3m-Myeloid-granulocyte|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.16e-04 | 149 | 35 | 3 | 9c4837aa63e46382ff45a41c72beb5722b3ada19 | |
| ToppCell | Children_(3_yrs)-Immune-mast_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.24e-04 | 151 | 35 | 3 | bbf735c6433c3fc2feedb24ed6f48c51d545fb60 | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.29e-04 | 152 | 35 | 3 | 854c841c1fc6300b7e9be9c98cbf9b0ce2678690 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Granulocytic|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.42e-04 | 155 | 35 | 3 | 51f6447945389649d99dcf7603b396195c631ead | |
| ToppCell | Adult-Immune-mast_cell-D122|Adult / Lineage, Cell type, age group and donor | 2.42e-04 | 155 | 35 | 3 | 7c9de0591d1bf756b8e268b278bbe10bd5415dcd | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Granulocytic-Mast_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.42e-04 | 155 | 35 | 3 | 23dc71cab28094ca0ac4d2baf4e24871ed107781 | |
| ToppCell | COVID-19-Mast_cells|COVID-19 / group, cell type (main and fine annotations) | 2.47e-04 | 156 | 35 | 3 | 159504d43421ee83b9ab484816333ae549c9c2fd | |
| ToppCell | COVID-19-Mast_cells-Mast_cells|COVID-19 / group, cell type (main and fine annotations) | 2.47e-04 | 156 | 35 | 3 | bc10b94673184ef384c6665b16a1209a8975a4f1 | |
| ToppCell | facs-Trachea-24m-Hematologic-myeloid-granulocyte-granulocyte_l26|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.47e-04 | 156 | 35 | 3 | da5cfa8fa9595613f04ce9511f8b42bad34d995a | |
| ToppCell | TCGA-Endometrium-Primary_Tumor-Endometrial_Adenocarcinoma-Serous_adenocarcinoma-3|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 2.51e-04 | 157 | 35 | 3 | ef70abc999be3a2c1eed7d21aef4b484f69d8567 | |
| ToppCell | severe_influenza-cDC|World / disease group, cell group and cell class (v2) | 2.71e-04 | 161 | 35 | 3 | 802f8cafb5f499e3b2ec0193d6eb1ac9320b9287 | |
| ToppCell | severe_influenza-cDC|severe_influenza / disease group, cell group and cell class (v2) | 2.71e-04 | 161 | 35 | 3 | 7716315b8bda904b346cea47edc2c0b507a345c2 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.76e-04 | 162 | 35 | 3 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | 10x5'-GI_large-bowel-Lymphocytic_T_CD4-Tfh|GI_large-bowel / Manually curated celltypes from each tissue | 2.81e-04 | 163 | 35 | 3 | 4104d3b9748b39cb0744c9be76db21bdda566a0d | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 2.87e-04 | 32 | 35 | 2 | b2d87153b4aefefd7b5e31ea67aa43e5f599e734 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 2.87e-04 | 32 | 35 | 2 | f5bcaacbddfb85439ebf5908762bf39cb72b727c | |
| ToppCell | nucseq-Immune-Hematopoietic-Granulocytic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.91e-04 | 165 | 35 | 3 | 37615622c736e43260c38016e7c9e565ac97a3e8 | |
| ToppCell | facs-Kidney-nan-24m-Epithelial-epithelial_cell_of_proximal_tubule|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.91e-04 | 165 | 35 | 3 | 02a09d0918b103aca21c36b42c5a8a8ebad8686c | |
| ToppCell | facs-Kidney-nan-24m-Epithelial-epithelial_cell_of_proximal_tubule|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.91e-04 | 165 | 35 | 3 | 906321cb5f299d77436fb5540fd8c52d7532beca | |
| ToppCell | nucseq-Immune-Hematopoietic-Granulocytic-Mast/Basophil|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.91e-04 | 165 | 35 | 3 | 640bb71e74a61df2fcb01ceeabe4c493ef836b21 | |
| ToppCell | nucseq-Immune-Hematopoietic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.91e-04 | 165 | 35 | 3 | f3df74b5763130c71c0a482a3a23f6b22acc2892 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells-Mast_cells_L.1.4.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.96e-04 | 166 | 35 | 3 | a42268a02a89fc97272e45c4cbe21acf04b7428c | |
| ToppCell | wk_20-22-Hematologic-Myeloid-Mast|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.96e-04 | 166 | 35 | 3 | 004ab6a1425d812c7ce572205875fd702d4a9659 | |
| ToppCell | facs-Skin-Anagen-24m-Epithelial-epidermal_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.01e-04 | 167 | 35 | 3 | 02c89069dcd0e87f7502e32b14e7cbd3cab81a09 | |
| ToppCell | Control-Mast_cells|Control / group, cell type (main and fine annotations) | 3.12e-04 | 169 | 35 | 3 | fdb9abca1d0f4fdc32dd8ac6231651ef34aa5afb | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_neutrophil-granulo-eo/baso/mast-eosinophil|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.12e-04 | 169 | 35 | 3 | f68195510b91e287fe1507455ca067ece77a3897 | |
| ToppCell | 356C-Myeloid-Dendritic-cDC_activated|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 3.12e-04 | 169 | 35 | 3 | 44d201361eb497222a4972a0e10bac1e05dcfd0a | |
| ToppCell | Control-Mast_cells-Mast_cells|Control / group, cell type (main and fine annotations) | 3.17e-04 | 170 | 35 | 3 | c80f6d29096c372da95a8407f402349ff1bb7018 | |
| ToppCell | 356C-Myeloid-Dendritic-cDC_activated|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 3.17e-04 | 170 | 35 | 3 | 513d9036aa41d4d902da8baa66a66206abb6f3b0 | |
| ToppCell | wk_20-22-Hematologic-Myeloid-Eosinophil|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 3.23e-04 | 171 | 35 | 3 | fa6e856e62b82ec4972e0098e73f237cc611891f | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-brush_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.23e-04 | 171 | 35 | 3 | 007f148f4611ea1826edfa9f91ced36541ad9f5a | |
| ToppCell | control-Myeloid-Eosinophils|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 3.23e-04 | 171 | 35 | 3 | 82f736c33ed96c0865618e8f8eb82a5487126bdc | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-Epcam____brush_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.23e-04 | 171 | 35 | 3 | 8e7223ba447947cdf4e1c82a52fd90439cf3d8f6 | |
| ToppCell | E15.5-Epithelial-epithelial_progenitor_cell-epithelial_unknown_3|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.28e-04 | 172 | 35 | 3 | a8b33d8ebc56e442a2ad6ac7dafd0c887571bd95 | |
| ToppCell | wk_15-18-Hematologic-Myeloid-Mast|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.28e-04 | 172 | 35 | 3 | a7146c255031207e64682ef767884b11c96e0d59 | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_10|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.34e-04 | 173 | 35 | 3 | 09a13407a41ff2cba82fc417b72bf9a24ce6c42e | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_10|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.34e-04 | 173 | 35 | 3 | bfec038a6783f166240da4861e100643c6ea80a5 | |
| ToppCell | 10x3'2.3-week_12-13-Myeloid_neutrophil-granulo-eo/baso/mast-eosinophil|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.34e-04 | 173 | 35 | 3 | 1e4afa020fae682521335b440ccd33c16f37156f | |
| ToppCell | wk_15-18-Hematologic-Myeloid-Eosinophil|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.34e-04 | 173 | 35 | 3 | a85cead231e03945fabbc7762540ad21fe4299df | |
| ToppCell | 10x3'2.3-week_17-19-Hematopoietic-HSC/MPP_and_pro-eo/baso/mast_precursor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.40e-04 | 174 | 35 | 3 | 64d13a7a9757e85f4f4af876c687dd18a7efa01a | |
| ToppCell | 10x5'-GI_small-bowel-Mast|GI_small-bowel / Manually curated celltypes from each tissue | 3.40e-04 | 174 | 35 | 3 | e94c980b25edfd0e8598c416828801fcc00e8ead | |
| ToppCell | 10x5'-GI_small-bowel-Mast-Mast_cells|GI_small-bowel / Manually curated celltypes from each tissue | 3.40e-04 | 174 | 35 | 3 | 05525bf0a2bde2be4f7c147b17a24530ce8819e0 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Hematopoietic-Myeloid-CLC+_Mast_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.40e-04 | 174 | 35 | 3 | 36080fa12497faa752ff07ae52cd3864053eafef | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Dendritic-dendritic_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.45e-04 | 175 | 35 | 3 | 393da565f61ba640410419a0cabaaf5c1056580a | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Dendritic-dendritic_cell-Migratory_DCs|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.45e-04 | 175 | 35 | 3 | 271b56d4ab940959d28ca4b86ce2750350dfc717 | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_neutrophil-granulo-eo/baso/mast-basophil|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.45e-04 | 175 | 35 | 3 | ba1befc4e5f0167452f9ceace39377d16136dfa9 | |
| ToppCell | facs-Kidney-nan-18m-Epithelial-epithelial_cell_of_proximal_tubule|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.45e-04 | 175 | 35 | 3 | 076ad81d6cbeea5512393d192af3ab5aa1f82975 | |
| ToppCell | facs-Kidney-nan-18m-Epithelial-epithelial_cell_of_proximal_tubule|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.45e-04 | 175 | 35 | 3 | 445ccb9744a3a9ff37164c532afbe769d306b6c8 | |
| ToppCell | facs-Marrow-B-cells-24m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.45e-04 | 175 | 35 | 3 | 887e75fc90e59a6394d62f3c048a9cfdf6707725 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Dendritic-dendritic_cell-Migratory_DCs-Migratory_DCs_L.1.2.1.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.45e-04 | 175 | 35 | 3 | 5168340c6045bbc7d67276afb719b051d1cb65a2 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.51e-04 | 176 | 35 | 3 | c6484334187f64cd00cd35e77d8ae436556b4260 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Hematopoietic-Myeloid-CLC+_Mast_cell|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.51e-04 | 176 | 35 | 3 | 183ba1aa5cf594b88ec08e0e41241668b51256a9 | |
| ToppCell | PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.51e-04 | 176 | 35 | 3 | b0b87eebcf5c994386b39ca607e17f10e9d9de74 | |
| ToppCell | IIH-mDC1-|IIH / Condition, Cell_class and T cell subcluster | 3.51e-04 | 176 | 35 | 3 | bb80a3e595d071f6cc8b042984b8d9490e377eef | |
| ToppCell | IIH-mDC1|IIH / Condition, Cell_class and T cell subcluster | 3.51e-04 | 176 | 35 | 3 | a75dc132a1061006fd1cb305bd314784fca07ea6 | |
| ToppCell | Dendritic_Cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 3.57e-04 | 177 | 35 | 3 | d2cd081bdda0eba9f6f6473c4d3939e4bee3440e | |
| ToppCell | control-Others-CD34+_GATA2+_cells|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 3.63e-04 | 178 | 35 | 3 | 2120bd3e099b0b271bf079db9827a2f3eee2f909 | |
| ToppCell | mild_COVID-19_(asymptomatic)-cDC|World / disease group, cell group and cell class (v2) | 3.75e-04 | 180 | 35 | 3 | 68d1c867734fb2977b01ac686b20bf602f9a6b72 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-alveolar_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.81e-04 | 181 | 35 | 3 | 8fcdab61fad2efd324d2b27c58f5a594f1dc15de | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-CLC+_Mast_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.81e-04 | 181 | 35 | 3 | 338c7362d258a87f1a6b1a65376f5394d4b2b4b2 | |
| ToppCell | NS-moderate-d_16-33-Lymphoid-NK|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.87e-04 | 182 | 35 | 3 | fb503f8ecd013f1f2161a5841572b57cfcddb6fa | |
| ToppCell | B_cells-ABCs|B_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 3.94e-04 | 183 | 35 | 3 | bf9c6fe3ce4e44e4056027257eab8448c39c4fb8 | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_neutrophil-granulo-eo/baso/mast-eosinophil|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.00e-04 | 184 | 35 | 3 | ce31684772e47a294155f368e50b49753f7c8e87 | |
| ToppCell | control-Myeloid-Eosinophils|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 4.00e-04 | 184 | 35 | 3 | fad517d047e8eaeaa5bd4f311d770880568dd13c | |
| ToppCell | moderate-Lymphoid-NK|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.06e-04 | 185 | 35 | 3 | 4979a787acbc9b4ca8defe91cc79b674e51af1bf | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.19e-04 | 187 | 35 | 3 | e3095455d2f255854f339f6b05fa87852af0700f | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_neutrophil-granulo-eo/baso/mast-basophil|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.26e-04 | 188 | 35 | 3 | b4d695c373195d389e0a579e9589e87433286b24 | |
| ToppCell | moderate-Lymphoid-NK|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.33e-04 | 189 | 35 | 3 | 22a19365782003c18ec8dddcdbfdaa82c4e330f6 | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.46e-04 | 191 | 35 | 3 | 9c5d88f0d3c834c2419ec3da74652175153ba9df | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.46e-04 | 191 | 35 | 3 | a7494191a92984e5f53610bbbedd6714e9169e1c | |
| ToppCell | 10x3'2.3-week_17-19-Myeloid_neutrophil-granulo-eo/baso/mast-mast_cell|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.53e-04 | 192 | 35 | 3 | 758ca0dacf313787effda36e6d1adb809e5b3a4e | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.0.3|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.60e-04 | 193 | 35 | 3 | 2a32f749224942974f45af5c0937609c5f2e7664 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-mature_enterocytic-Enterocyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.67e-04 | 194 | 35 | 3 | fcbf9c4f3801ab1a34fcd62c752fabc97fc7bde1 | |
| ToppCell | 10x3'2.3-week_17-19-Myeloid_neutrophil-granulo-eo/baso/mast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.74e-04 | 195 | 35 | 3 | fbedb9978ded857fd35c2a8664f7579f42edaa36 | |
| ToppCell | C_05|World / shred on cell type and cluster | 4.81e-04 | 196 | 35 | 3 | bf4dfb460a153dbafb2b9b12b360c8757cec22cd | |
| ToppCell | hematopoetic_progenitors-CD34+_MEP_1|hematopoetic_progenitors / Lineage and Cell class | 4.88e-04 | 197 | 35 | 3 | 6172a1b98ff840d9174b1ab20ba0c202a7ef87af | |
| ToppCell | 390C-Myeloid-Dendritic|390C / Donor, Lineage, Cell class and subclass (all cells) | 4.88e-04 | 197 | 35 | 3 | 424526c94b9a73c1c28ddc65dfba53aba5c6b2d2 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-DC2-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.95e-04 | 198 | 35 | 3 | c58e2d3a21fcca9f1accccc5303ca4222b6c8432 | |
| ToppCell | distal-3-Hematologic-Myeloid_Dendritic_Type_1|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.95e-04 | 198 | 35 | 3 | b21227c7366ef79b36048509a91d2d35fd5e4956 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-DC2|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.95e-04 | 198 | 35 | 3 | f4ff9520598ebc52b3a1f31eee766957983e16b4 | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_neutrophil-granulo-eo/baso/mast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.95e-04 | 198 | 35 | 3 | a1247a5efd92f95c6227c0e71dc8a0427eb54b7f | |
| ToppCell | distal-Hematologic-Myeloid_Dendritic_Type_1-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.03e-04 | 199 | 35 | 3 | 3860f30114b54abff91898308df71b8b4e05b51e | |
| ToppCell | Bronchial-10x5prime-Immune_Myeloid-Dendritic_cell|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.03e-04 | 199 | 35 | 3 | 946d904a880c0e211861fcec7e120853ffade282 | |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma|TCGA-Bladder / Sample_Type by Project: Shred V9 | 5.03e-04 | 199 | 35 | 3 | 8ee3dbc0a92de5f3865e5484970ae2aab7d1a956 | |
| ToppCell | TCGA-Bladder-Primary_Tumor|TCGA-Bladder / Sample_Type by Project: Shred V9 | 5.03e-04 | 199 | 35 | 3 | c403e28def2e14f5931cd73b4fb9a4078c0439f8 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10-Neuronal-Intermediate|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 5.03e-04 | 199 | 35 | 3 | cf592d93612023a13de21e0fb8c6b13714f9af71 | |
| ToppCell | Bronchial-NucSeq-Stromal-Chondrocytic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.10e-04 | 200 | 35 | 3 | b7b9441fa7ab0d43741a2ebd5ec1a48d537c6d47 | |
| Drug | 2-azetidinone | 1.41e-08 | 18 | 35 | 4 | CID000136721 | |
| Drug | tele-methylhistamine | 3.33e-07 | 38 | 35 | 4 | CID000003614 | |
| Drug | methylimidazoleacetic acid | 2.23e-06 | 17 | 35 | 3 | CID000075810 | |
| Drug | AC1Q6A3R | 2.30e-06 | 2 | 35 | 2 | CID000160583 | |
| Drug | gypsetin | 2.30e-06 | 2 | 35 | 2 | CID000160406 | |
| Drug | glisoprenin B | 2.30e-06 | 2 | 35 | 2 | CID006438769 | |
| Drug | NSC292654 | 2.30e-06 | 2 | 35 | 2 | CID000325064 | |
| Drug | 23-methyl-UDCA | 2.30e-06 | 2 | 35 | 2 | CID000196679 | |
| Drug | 7,7-difluorocholestanol | 2.30e-06 | 2 | 35 | 2 | CID000196646 | |
| Drug | 6,6-difluorocholestanol | 2.30e-06 | 2 | 35 | 2 | CID000196647 | |
| Drug | Aplus | 2.30e-06 | 2 | 35 | 2 | CID000028221 | |
| Drug | Ro 16-0521 | 2.30e-06 | 2 | 35 | 2 | CID000065657 | |
| Drug | AC1NT076 | 2.30e-06 | 2 | 35 | 2 | CID005321102 | |
| Drug | xymedon | 2.30e-06 | 2 | 35 | 2 | CID000121931 | |
| Drug | atracurium besylate | 5.02e-06 | 22 | 35 | 3 | CID000047320 | |
| Drug | AC1L2Q3W | 5.02e-06 | 22 | 35 | 3 | CID000126312 | |
| Drug | olean-12-ene | 6.88e-06 | 3 | 35 | 2 | CID000612780 | |
| Drug | thymidine glycol monophosphate | 6.88e-06 | 3 | 35 | 2 | CID000165415 | |
| Drug | Purpactin A | 6.88e-06 | 3 | 35 | 2 | CID000131673 | |
| Drug | glisoprenin A | 6.88e-06 | 3 | 35 | 2 | CID006438768 | |
| Drug | Nsc692258 | 6.88e-06 | 3 | 35 | 2 | CID000469167 | |
| Drug | ethyl 6-chlorochroman-2-carboxylate | 6.88e-06 | 3 | 35 | 2 | CID000169516 | |
| Drug | zaragozic acid D3 | 6.88e-06 | 3 | 35 | 2 | CID006475792 | |
| Drug | 4-chloro-o-phenylenediamine | 1.37e-05 | 4 | 35 | 2 | CID000007263 | |
| Drug | Cgs-26214 | 1.37e-05 | 4 | 35 | 2 | CID000133077 | |
| Drug | AC1L3QAA | 1.37e-05 | 4 | 35 | 2 | CID000093484 | |
| Drug | isochromophilone VII | 1.37e-05 | 4 | 35 | 2 | CID006443571 | |
| Drug | isochromophilone VIII | 1.37e-05 | 4 | 35 | 2 | CID006443572 | |
| Drug | lupinine | 1.37e-05 | 4 | 35 | 2 | CID000091461 | |
| Drug | Brunfelsamidine | 1.37e-05 | 4 | 35 | 2 | CID005281683 | |
| Drug | acaterin | 1.37e-05 | 4 | 35 | 2 | CID000126830 | |
| Drug | atracurium | 2.11e-05 | 35 | 35 | 3 | CID000047319 | |
| Drug | NSD 1039 | 2.29e-05 | 5 | 35 | 2 | CID000193408 | |
| Drug | NSD 1024 | 2.29e-05 | 5 | 35 | 2 | CID000188951 | |
| Drug | NSC-110264 | 2.29e-05 | 5 | 35 | 2 | CID000269324 | |
| Drug | cyclononane | 2.29e-05 | 5 | 35 | 2 | CID000136143 | |
| Drug | Attpsa | 3.43e-05 | 6 | 35 | 2 | CID005487511 | |
| Drug | SCH 48461 | 3.43e-05 | 6 | 35 | 2 | CID000132832 | |
| Drug | ioxaglate | 4.80e-05 | 7 | 35 | 2 | CID000003742 | |
| Drug | Telebrix | 4.80e-05 | 7 | 35 | 2 | CID000034536 | |
| Drug | AC1Q6RZL | 5.15e-05 | 47 | 35 | 3 | CID000001144 | |
| Drug | neoxaline | 6.39e-05 | 8 | 35 | 2 | CID006440491 | |
| Drug | CP-113,818 | 6.39e-05 | 8 | 35 | 2 | CID000164373 | |
| Drug | 4-methylumbelliferyl elaidate | 6.39e-05 | 8 | 35 | 2 | CID000087585 | |
| Drug | arjunolic acid | 6.39e-05 | 8 | 35 | 2 | CID000073641 | |
| Drug | cetyl ether | 8.21e-05 | 9 | 35 | 2 | CID000077757 | |
| Drug | propanoyl | 8.21e-05 | 9 | 35 | 2 | CID000139982 | |
| Drug | 1,6-bis(cyclohexyloximinocarbonyl)hexane | 8.21e-05 | 9 | 35 | 2 | ctd:C036535 | |
| Drug | daphnodorin C | 8.21e-05 | 9 | 35 | 2 | CID000072428 | |
| Drug | PD138142-15 | 8.21e-05 | 9 | 35 | 2 | CID003025787 | |
| Drug | 1c5s | 1.03e-04 | 10 | 35 | 2 | CID000444753 | |
| Drug | N-methylisatoic anhydride | 1.03e-04 | 10 | 35 | 2 | CID000025160 | |
| Drug | AC1NUP69 | 1.03e-04 | 10 | 35 | 2 | CID005487154 | |
| Drug | 6-hydroxydopa | 1.03e-04 | 10 | 35 | 2 | CID000033755 | |
| Drug | stearoylcarnitine | 1.03e-04 | 10 | 35 | 2 | CID000005282 | |
| Drug | fenpropathrin | 1.18e-04 | 62 | 35 | 3 | CID000047326 | |
| Drug | cyclandelate | 1.25e-04 | 11 | 35 | 2 | CID000002893 | |
| Drug | acetylshikonin | 1.25e-04 | 11 | 35 | 2 | CID000032464 | |
| Drug | Z-ala-ala-lys-mna | 1.25e-04 | 11 | 35 | 2 | CID005486901 | |
| Drug | etiroxate | 1.25e-04 | 11 | 35 | 2 | CID000065683 | |
| Drug | pimaradiene | 1.25e-04 | 11 | 35 | 2 | CID000440909 | |
| Drug | daphnodorin A | 1.25e-04 | 11 | 35 | 2 | CID000072426 | |
| Drug | AC1NSU64 | 1.25e-04 | 11 | 35 | 2 | CID005316303 | |
| Drug | methylhistamine | 1.25e-04 | 11 | 35 | 2 | CID000000912 | |
| Drug | succinylcholine | 1.30e-04 | 64 | 35 | 3 | CID000005314 | |
| Drug | bis(5-amidino-2-benzimidazolyl)methane | 1.50e-04 | 12 | 35 | 2 | CID000002386 | |
| Drug | NSC-648146 | 1.50e-04 | 12 | 35 | 2 | CID000372649 | |
| Drug | etofibrate | 1.50e-04 | 12 | 35 | 2 | CID000065777 | |
| Drug | Elocom | 1.50e-04 | 12 | 35 | 2 | CID000123620 | |
| Drug | AC1Q6A7C | 1.50e-04 | 12 | 35 | 2 | CID000092807 | |
| Drug | 4-amidinophenylpyruvic acid | 1.50e-04 | 12 | 35 | 2 | CID000151496 | |
| Drug | AC1MHGAG | 1.50e-04 | 12 | 35 | 2 | CID003025954 | |
| Drug | tryptophan-leucine | 1.77e-04 | 13 | 35 | 2 | CID000323786 | |
| Drug | maslinic acid | 1.77e-04 | 13 | 35 | 2 | CID000073659 | |
| Drug | Z-ARR-AFC | 1.77e-04 | 13 | 35 | 2 | CID000125067 | |
| Drug | Nk3201 | 1.77e-04 | 13 | 35 | 2 | CID000213050 | |
| Drug | dinitrobenzene | 1.92e-04 | 73 | 35 | 3 | CID000007452 | |
| Drug | homoserine | 1.92e-04 | 73 | 35 | 3 | CID000000779 | |
| Drug | ABPH | 2.07e-04 | 14 | 35 | 2 | CID000092377 | |
| Drug | swertiamarin | 2.07e-04 | 14 | 35 | 2 | ctd:C013270 | |
| Drug | TCNE | 2.07e-04 | 14 | 35 | 2 | CID000012635 | |
| Drug | F 1394 | 2.07e-04 | 14 | 35 | 2 | CID000178067 | |
| Drug | Dizocilpine maleate [77086-22-7]; Up 200; 11.8uM; PC3; HT_HG-U133A | 2.18e-04 | 194 | 35 | 4 | 2069_UP | |
| Drug | Urapidil hydrochloride [64887-14-5]; Down 200; 9.4uM; PC3; HT_HG-U133A | 2.35e-04 | 198 | 35 | 4 | 6696_DN | |
| Drug | acryloyl chloride | 2.38e-04 | 15 | 35 | 2 | CID000013140 | |
| Drug | BMY 42393 | 2.38e-04 | 15 | 35 | 2 | CID000131961 | |
| Drug | AC1L4Q08 | 2.38e-04 | 15 | 35 | 2 | CID000161747 | |
| Drug | AC1L9K4M | 2.38e-04 | 15 | 35 | 2 | CID000446820 | |
| Drug | FdTTP | 2.38e-04 | 15 | 35 | 2 | CID000162005 | |
| Drug | brocresine | 2.38e-04 | 15 | 35 | 2 | CID000011151 | |
| Drug | 5 alpha-androstan-3-one | 2.72e-04 | 16 | 35 | 2 | CID000102028 | |
| Drug | (E)-4-aminohex-4-enoic acid | 2.72e-04 | 16 | 35 | 2 | CID005288385 | |
| Drug | AC1L9HBF | 2.72e-04 | 16 | 35 | 2 | CID000445037 | |
| Drug | oleoylcarnitine | 2.72e-04 | 16 | 35 | 2 | CID006441392 | |
| Drug | thymidine glycol | 2.72e-04 | 16 | 35 | 2 | CID003035041 | |
| Drug | Amino nucleoside | 2.72e-04 | 16 | 35 | 2 | CID003000338 | |
| Drug | Aa1 | 2.81e-04 | 83 | 35 | 3 | CID009549188 | |
| Drug | Qing Ye Dan | 3.08e-04 | 17 | 35 | 2 | ctd:C587274 | |
| Drug | tetramethylammonium chloride | 3.08e-04 | 17 | 35 | 2 | CID000006379 | |
| Drug | clinofibrate | 3.08e-04 | 17 | 35 | 2 | CID000002787 | |
| Disease | cholesteryl ester 24:4 measurement | 2.86e-05 | 7 | 35 | 2 | EFO_0021447 | |
| Disease | tryptase beta-2 measurement | 4.89e-05 | 9 | 35 | 2 | EFO_0008306 | |
| Disease | cholesteryl ester 24:5 measurement | 8.95e-05 | 12 | 35 | 2 | EFO_0021448 | |
| Disease | response to radiation, Urinary retention | 1.84e-04 | 17 | 35 | 2 | GO_0009314, HP_0000016 | |
| Disease | spinal stenosis | 1.84e-04 | 17 | 35 | 2 | EFO_0007490 | |
| Disease | urticaria | 2.56e-04 | 20 | 35 | 2 | EFO_0005531 | |
| Disease | pneumonia, COVID-19 | 3.27e-04 | 113 | 35 | 3 | EFO_0003106, MONDO_0100096 | |
| Disease | trauma exposure measurement | 1.11e-03 | 172 | 35 | 3 | EFO_0010703 | |
| Disease | multiple sclerosis (is_marker_for) | 1.55e-03 | 49 | 35 | 2 | DOID:2377 (is_marker_for) | |
| Disease | Seizures | 2.19e-03 | 218 | 35 | 3 | C0036572 | |
| Disease | basophil measurement | 2.32e-03 | 60 | 35 | 2 | EFO_0803539 | |
| Disease | heart rate | 2.39e-03 | 225 | 35 | 3 | EFO_0004326 | |
| Disease | Microcephaly | 2.88e-03 | 67 | 35 | 2 | C0025958 | |
| Disease | vital capacity | 3.05e-03 | 1236 | 35 | 6 | EFO_0004312 | |
| Disease | lung cancer (is_implicated_in) | 3.50e-03 | 74 | 35 | 2 | DOID:1324 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VYAYVFEHRASTLSW | 456 | P22303 | |
| FLYIYYVHWSISTAD | 111 | Q86UN6 | |
| WTALRHQYTQTAILY | 666 | O75815 | |
| SIELTSYIYIWENYR | 91 | Q6ZNB7 | |
| VLRTTSTVYNYDYIW | 451 | P19801 | |
| SLSWYNHFYVSVCLY | 481 | Q7Z2K6 | |
| YYYNASTQRTVWHRP | 81 | Q9C0H5 | |
| YYTTHWTSLRYSINV | 3996 | Q9NZR2 | |
| VTSIVLYFQYVYWLH | 236 | Q969X1 | |
| SYSRVYLLYHTWSQV | 151 | Q86YN1 | |
| LSNWYHFLVTRLLYS | 301 | Q9BW27 | |
| YRLFLSHSLYWEVSS | 406 | Q86V85 | |
| TARYIYISYLENAWT | 521 | Q6ZSS7 | |
| IILYYTVYVWNRSSL | 926 | Q9UMZ3 | |
| RYWHSTATYAIATEV | 331 | Q5EBM0 | |
| VGHYTQVVWYSSYLV | 136 | P54108 | |
| YAIVGIVWLTQYYTS | 111 | Q9Y4D2 | |
| NTYRSRKYTSWYVAL | 246 | P09038 | |
| VAHFSYNWTFYTLLT | 296 | Q9NRA2 | |
| YAVYLLTVLYHESWN | 221 | P82673 | |
| SATTYYWYREALNIS | 201 | Q9H2J7 | |
| IYTRVTYYLDWIHHY | 256 | Q15661 | |
| IYTRVTYYLDWIHHY | 256 | P20231 | |
| TSYSNYYRTWNVVVH | 411 | P35610 | |
| SYLWYSAHNSTTVIV | 526 | Q9Y289 | |
| SRTRTGKYTDYYIWH | 226 | Q07837 | |
| SAVSYFWYRQTLNIT | 156 | Q96N87 | |
| YRTWNVVVHDWLYSY | 391 | O75908 | |
| LARKYVYSLYWSTLT | 341 | P29973 | |
| KYIYSLYWSTLTLTT | 351 | Q16281 | |
| DYSELTWYLTSVYQH | 176 | P46094 | |
| LFLTWVSYYESHINS | 201 | Q76I76 | |
| HFSNYRITWIMYTAY | 131 | Q6GV28 | |
| TYIHSWNLARFVFTY | 71 | Q9Y6I8 | |
| SYVAHERLSYAFSVW | 176 | Q15672 |